Literature DB >> 19547864

HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties--a review.

Alberto Luis Epstein1.   

Abstract

Amplicons are defective and non-integrative vectors derived from herpes simplex virus type 1. As the vector genome carries no virus genes, amplicons are both non-toxic for the infected cells and non-pathogenic for the inoculated organisms. In addition, the large transgenic capacity of amplicons, which allow delivery of up to 150 Kbp of foreign DNA, makes these vectors one of the most powerful, interesting and versatile gene delivery platforms. We present here recent technological developments that have significantly improved and extended the use of amplicons, both in cultured cells and in living organisms. In addition, this review also discusses the many difficulties still pending to be solved, in order to achieve stable and physiologically regulated transgene expression.

Entities:  

Mesh:

Year:  2009        PMID: 19547864     DOI: 10.1590/s0074-02762009000300002

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  10 in total

1.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

Review 2.  Transfection techniques for neuronal cells.

Authors:  Daniela Karra; Ralf Dahm
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 3.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

4.  Target-specific projections of amygdala somatostatin-expressing neurons to the hypothalamus and brainstem.

Authors:  Jane J Bartonjo; Robert F Lundy
Journal:  Chem Senses       Date:  2022-01-01       Impact factor: 4.985

5.  Viral hybrid vectors for somatic integration - are they the better solution?

Authors:  Nadine Müther; Nadja Noske; Anja Ehrhardt
Journal:  Viruses       Date:  2009-12-15       Impact factor: 5.048

6.  Induction of humoral responses to BHV-1 glycoprotein D expressed by HSV-1 amplicon vectors.

Authors:  Andrea Maria Blanc; Mabel Beatriz Berois; Lorena Magalí Tomé; Alberto L Epstein; Juan Ramón Arbiza
Journal:  J Vet Sci       Date:  2012-03       Impact factor: 1.672

Review 7.  Cellular unfolded protein response against viruses used in gene therapy.

Authors:  Dwaipayan Sen; Balaji Balakrishnan; Giridhara R Jayandharan
Journal:  Front Microbiol       Date:  2014-05-26       Impact factor: 5.640

8.  Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells.

Authors:  Marie Soukupová; Silvia Zucchini; Pascal Trempat; Selene Ingusci; Coline Perrier-Biollay; Mario Barbieri; Stefano Cattaneo; Barbara Bettegazzi; Simonetta Falzoni; Hervé Berthommé; Michele Simonato
Journal:  Mol Ther Methods Clin Dev       Date:  2021-03-29       Impact factor: 6.698

9.  Herpes Virus Amplicon Vectors.

Authors:  Suresh de Silva; William J Bowers
Journal:  Viruses       Date:  2009-12-01       Impact factor: 5.048

10.  Silencing Status Epilepticus-Induced BDNF Expression with Herpes Simplex Virus Type-1 Based Amplicon Vectors.

Authors:  Chiara Falcicchia; Pascal Trempat; Anna Binaschi; Coline Perrier-Biollay; Paolo Roncon; Marie Soukupova; Hervé Berthommé; Michele Simonato
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.